Navamedic
Develops, produces, and commercializes medicines and related health products.
NAVA | OL
Overview
Corporate Details
- ISIN(s):
- NO0010205966
- LEI:
- 529900LKVQOR2SRUJU71
- Country:
- Norway
- Address:
- Henrik Ibsens gate 100, 0255 OSLO
- Website:
- https://navamedic.com/
- Sector:
- Wholesale and retail trade
- Industry:
- Other specialized wholesale
Description
Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-07-11 14:16 |
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_JD…
|
English | PDF • 79.4 KB | ||
| 2025-07-11 14:16 |
Navamedic ASA: Mandatory notice of trade
|
English | HTML • 862 bytes | ||
| 2025-07-10 10:49 |
Navamedic ASA: Updated key information relating to the rights issue
|
English | HTML • 10.0 KB | ||
| 2025-06-29 13:36 |
Navamedic ASA - Additional underwriting commitments in the Rights Issue
|
English | HTML • 8.8 KB | ||
| 2025-06-27 14:14 |
Navamedic ASA: First approval of the medical device OraFID® as primary package …
|
English | HTML • 2.8 KB | ||
| 2025-06-24 08:00 |
Navamedic ASA - Investor presentation regarding the acquisition of the business…
|
English | PDF • 1.1 MB | ||
| 2025-06-24 08:00 |
Navamedic ASA - Investor presentation regarding the acquisition of the business…
|
English | HTML • 1.8 KB | ||
| 2025-06-23 17:35 |
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_Pr…
|
English | PDF • 80.7 KB | ||
| 2025-06-23 17:35 |
Navamedic ASA: Mandatory notice of trade
|
English | HTML • 876 bytes | ||
| 2025-06-23 12:45 |
Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in conne…
|
Norwegian | PDF • 1.3 MB | ||
| 2025-06-23 12:45 |
Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in conne…
|
English | HTML • 9.9 KB | ||
| 2025-06-23 08:15 |
Navamedic ASA: Key information relating to the Rights Issue
|
English | HTML • 9.8 KB | ||
| 2025-06-23 08:00 |
Navamedic ASA expands into addiction treatment through the acquisition of the b…
|
English | HTML • 19.0 KB | ||
| 2025-06-04 10:29 |
Navamedic ASA: Minutes of Annual General Meeting - Attachment: Navamedic_Minute…
|
Norwegian | PDF • 545.6 KB | ||
| 2025-06-04 10:29 |
Navamedic ASA: Minutes of Annual General Meeting
|
English | HTML • 1.0 KB |
Automate Your Workflow. Get a real-time feed of all Navamedic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Navamedic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Navamedic via our API.
Peer Companies
